• Andrey Kondratovich
  • About company
  • On November 1st, Andrey Kondratovich, our friend and associate, COO of our company, passed away.

    This is a huge and terrible loss for us as professionals, an irreparable personal loss. Andrey was a wonderful, tactful person, a perfect leader and an excellent professional. He put all his heart into the building of HemaCore trying to implement there his own vision of an ideal company; this is what he was building together with all of us, working for up to 14 hours per day.

    Andrey was a pure soul, a perfectly decent person. The more is the pity to realize that he is no more with us.

    We will always remember him.

    We will continue developing HemaCore the way Andrew would like to see him. A company trying to implement something that seems impossible to the majority of people, a company changing medicine for the better, a company seeking to help the doctors save thousands of human lives. While each saved person is as necessary and dear to someone as Andrey was dear and necessary to us. To save even one human life for those who care and love is a decent mission.

    Our heartfelt condolences go to the Andrey's family.

    I. Pivovarov
  • HemaCore is a biotech company, develops medical devices and methods for hematology. HemaCore was founded in April, 2010 by a group of scientist who invented and patented the Thrombodynamics – a new global assay for monitoring and prognosis of blood coagulation disorders: bleeding and thrombosis, precursors of heart attacks and strokes. In 2010 HemaCore received the first round of investments from RUSNANO and Sberbank Capital intended for developing the analyser, consumables and organization of clinical trials in Russia. HemaCore has completed final design of product for the serial production of the Thrombodynamics analyzer and disposables. In Europe and USA: Research Use Only.

    More


1994

First publication on autowave model of clot formation

1997

First experimental setup designed

2002

Research showed, that
clot formation speed
in hemophilic plasma is lower

2007

Patent application submitted

2008
  • 17
    march
    2008

    First prototype of clinical device

  • 07
    july
    2008

    Filed application to RUSNANO

2009
  • 01
    september
    2009

    Project was approved by RUSNANO

  • 30
    september
    2009

    MedIn LLC incorporated

2010
  • 23
    april
    2010

    Sign of investment agreement

  • 14
    october
    2010

    Project start

2011
  • 14
    july
    2011

    Pilot production launched

  • 25
    july
    2011

    Project is presented on ISTH-2011

2012
  • 03
    october
    2012

    The first workshop by HemaCore

  • 01
    november
    2012

    Sales start in Russia

2013
2014
2015
1994 2013 2014
Close